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Rhesus monkeys were conditioned to press on levers and receive intravenous infusions of cocaine or ketamine. 
Experimental conditions provided several different doses of drug during each of two daily 130 min sessions; as a result, a dose- 
response curve relating rate of responding to dose/injection for self-administered drug was obtained within each session. 
Relative rate-maintaining effects of nomifensine and cocaine in monkeys on baseline conditions of cocaine self-administration, 
and rate-maintaining effects of ketamine, phencyclidine and MK-801 in monkeys on baseline conditions of ketamine self- 
administration, compared favorably with relative rate-maintaining effects of these substances obtained in more traditional 
paradigms. 
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Introduction 
In 1980, Woods [l] described in this journal a 
procedure for rapidly evaluating reinforcing 
effects of i.v. delivered codeine in rhesus mon- 
keys. Using apparatus described by Deneau et 
al. [2], Woods conditioned monkeys to press on 
levers when a stimulus light was illuminated, 
and receive i.v. injections of codeine. Thirty 
responses were required for each injection, 
which was followed by a lo-min time out period 
during which the stimulus light was turned off 
and responses had no consequences. Each 
session was 130 min in duration, and a 
maximum of 13 injections could be earned in a 
session; two sessions occurred daily, separated 
by approximately 4 hours. Once baseline rates 
of behavior were established with 0.32 mg/kg 
per inj. codeine, substitutions of saline or one of 
several doses of codeine were made once every 
four sessions, which was equivalent to once 
every other day. A dose-response curve, 
relating dose of codeine to rate of responding 
maintained by that dose, could be obtained 
within 2 - 4 weeks. 
Using this procedure, more than 180 opioid 
and non-opioid drugs have been evaluated [e.g., 
3,4]. In this paper, we evaluate a modification of 
this procedure, a modification that allows a 
dose-effect curve to be obtained for rate-main- 
taining effects of a drug in as few as one ses- 
sion. We evaluated cocaine and ketamine for 
their ability to maintain stable baseline rates of 
responding in two groups of monkeys, and 
observed effects of substituting the dopamine- 
uptake blocker nomifensine in cocaine-baseline 
monkeys and the non-competitive NMDA 
antagonists phencyclidine and MK-801 in 
ketamine-baseline monkeys. We compared data 
obtained using the modified procedure with 
previously published data obtained with these 
drugs in the original procedure. 
Methods 
Subjects 
Subjects were seven rhesus monkeys VMa- 
caca mulatta) of either sex, weighing between 
5.1 and 9.1 kg. Monkeys were fed 125-185 
grams of High Protein Purina Monkey Chow 
twice daily, at least 30 min prior to initiation of 
a self-administration session. Intravenous 
silastic catheters were surgically implanted in 
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each monkey using 10 mg/kg i.m. ketamine and 
15 mglkg i.v. pentobarbital as anesthetic. 
Catheters were implanted in jugular, femoral, 
or brachial veins, as necessary. The catheter 
passed subcutaneously from the site of the 
incision to the mid-scapular region, where it 
exited the monkey and continued, through a 
hollow restraining arm, to the outside rear of 
the cage. 
All but one subject had either short or long 
histories of self-administration of either cocaine 
or codeine under the conditions of the original 
paradigm. One monkey, in addition, had experi- 
ence responding on the lever to terminate infu- 
sions of histamine or kappa opioids. One 
monkey’s history was exclusively that of 
responding to terminate drug infusions. 
Apparatus 
The restraint and catheter protection device 
has been described in detail by Deneau et al. [2]. 
Monkeys were individually housed in stainless 
steel cages, measuring 33.3 x 76.2 x 91.4 cm 
deep. Each monkey wore a tubular stainless 
steel harness that protected the exit site of the 
catheter. A Teflon cloth jacket (Alice King Cha- 
tam Medical Arts, Los Angeles, CA) provided 
further protection for animals who tended to 
locate and pull their catheters. The harness 
was connected to a tubular, jointed arm that 
carried the catheter to the back of the cage 
where it joined tubing passing through a roller 
infusion pump (Watson and Marlow Co., Model 
MHRK 55; Falmouth, U.K.). 
A 15.4 cm2 stimulus panel was located on the 
side of each cage, approximately 10 cm from the 
front and 19 cm from the bottom of the cage. 
Across the top of the stimulus panel, 2.5 cm 
apart, were three circles, 2.5 cm in diameter, 
covered with translucent plastic and capable of 
being illuminated from behind by 5 W Christ- 
mas tree bulbs. The two side lights could be 
illuminated red and the center light could be 
illuminated green. Below each of the two red 
stimulus lights was a response lever (Model 
121-07; BRS-LVE, Beltsville, MD), capable of 
being operated by lo- 15 g of force. 
Experimental control was provided by 
individual IBM PCjr computers located in an 
adjoining room. BASIC software was used to 
control experimental procedures. 
Procedure 
Monkeys were adapted to restraining arms 
for 1 week or more; then an i.v. catheter was 
implanted and they were given the opportunity 
to respond and receive drug. As with the 
original paradigm, experimental sessions were 
limited to 130 min, and two sessions were 
scheduled each day, separated by at least 4 
hours. Each session was divided into four 
components; each component was signaled by 
illumination of a red stimulus light, and was 
separated from the following component by a 
lo-min intercomponent interval. No lights were 
illuminated, and responses had no conse- 
quences during the intercomponent interval. 
Except as noted below, a unique dose per 
injection of drug was available during each 
component. A component ended after 20 injec- 
tions of that particular dose were earned, or 25 
min had passed, whichever occurred first. 
Drugs were delivered on a fixed ratio 30 sched- 
ule and each injection was followed by a 45 s 
time out period, during which the red light 
was extinguished and responses had no 
consequences. Injections were accompanied by 
illumination of the center, green stimulus light. 
Drug concentration was kept constant through- 
out a session; doseslinj. were altered by adjust- 
ing duration of the infusion pump, which 
delivered 1 cm3 of drug solution per 5 s. The 
shortest duration was 0.1 s and always corre- 
sponded to a dose of ‘0’ on the dose-effect 
curves. Other doses, evaluated in one-half loga- 
rithm unit steps, were associated with 1.7, 5.0 
and 16.7 s infusion durations. A concentration 
of 0.05 mg/cm3 for a 5 kg monkey would result 
in doses of 0.003 mg/kg per inj. at an infusion 
duration of 1.7 s (0.3 cm31, 0.01 mglkg per inj. at 
an infusion duration of 5 s (1 cm?, and 0.03 mgl 
kg per inj. at an infusion duration of 16.7 s (3.3 
cm31. Four different permutations of these 
infusion durations were used. Each infusion 
duration appeared in a different position in the 
selected permutations: 0.1, 1.7, 5.0 and 16.7 s; 
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1.7,0.1,16.7 and 5.0 s; 5.0,16.7,1.7 and 0.1 s and 
16.7,5.0,0.1 and 1.7 s. These four permutations 
were used exclusively, with nearly equal fre- 
quency, except during the time behavior was 
being established. 
When a monkey was first exposed to the new 
procedure, doselinj. was usually left constant 
(0.003 mg/kg per inj. cocaine or 0.03 or 0.1 mgl 
kg per inj. ketaminel using 5-s infusion 
durations in each of the four components until 
rates of responding were greater than one 
response per second. The range of drug doses 
was then introduced, and behavior was allowed 
to stabilize. The range of doses was empirically 
selected so as to produce a monotonically 
increasing dose-response function. Thus, we 
selected for evaluation the ascending limb of 
the characteristically inverted U-shaped 
function relating doselinj. to rate of drug self- 
administration [e.g., 51. 
After response rates became relatively 
stable, saline was substituted for the baseline 
drug. The number of sessions before saline was 
substituted varied from eight to 60 (mean = 
361, but since there was no strict criteria as to 
when behavior was considered stable, this 
number does not reflect precisely the time 
required for behavior to become sufficiently 
stable to proceed with evaluation of other 
drugs. 
When saline was substituted, infusion dura- 
tions continued to be varied, as they were 
under drug condition, and the order of infusion 
durations was the order that would have been 
used for that session if the drug had been 
available. If rates of saline-maintained 
responding were higher than approximately 0.5 
responses per second at any infusion duration, 
saline was substituted again, two or three ses- 
sions later, until rates were consistently below 
0.5 responses per second. If rates of saline- 
maintained responding were quite high, 
consecutive saline sessions were given until 
rates declined. Saline substitutions continued 
on a periodic basis, three to four times each 
week, throughout the experiment. 
Test drugs were substituted during single 
sessions after rates of saline-contingent behav- 
ior were consistently lower than rates of 
cocaine- or ketamine-contingent behavior. 
Although rates of responding maintained by 
three doses (plus the “0” dose indicated by 0.1-s 
infusion durations) of test drug were measured 
in each session in which these drugs were 
evaluated, it was frequently the case that 
effects of additional doses needed to be exam- 
ined. This was accomplished by retesting that 
drug using a different concentration of drug 
solution, thereby evaluating a different range 
of three doses. All data obtained from a given 
drug were averaged together; some data points 
therefore include data obtained when that dose 
was available at more than one infusion dura- 
tion. 
Drugs 
Cocaine was purchased from Mallinckrodt, 
Inc., St. Louis, MO; phencyclidine and 
ketamine, from Warner Lambert/Parke-Davis, 
Morris Plains, NJ. Nomifensine was supplied 
by Hoecht-Roussel Pharmaceutical, Sommer- 
ville, NJ and MK-801, by Merck Sharp and 
Dohme Research Laboratory, Rahway, NJ. All 
drugs were prepared in sterile water. 
Results 
Cocaine-baseline 
Once baseline rates of responding appeared 
sufficiently stable, data from sixteen nearly 
consecutive sessions (exceptions were sessions 
in which saline or another drug was 
substituted) of cocaine availability were evalu- 
ated for effects of cocaine dose and dose order. 
The four doses of cocaine maintained differen- 
tial self-administration behavior within single 
130-min experimental sessions. Rate of 
responding maintained by cocaine increased as 
dose of cocaine increased, as shown in Fig. 1. 
The highest rate of responding for each 
monkey occurred at the largest dose tested, 
0.01 mg/kg per inj. 
The order of dose *presentation did not 
greatly affect the dose-response relation. 
Figure 2 shows that low rates of responding 
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Fig. 1. The ability of various doses of cocaine to maintain 
responding in three monkeys under conditions in which 
several doses of the drug were available in individual 130- 
min sessions. The symbols represent rates of responding 
averaged across 16 sessions for each monkey. Vertical lines 
are standard errors of the mean. 
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occurred at 0.01 mg/kg per inj. and 
intermediate rates occurred at 0.001 and 0.003 
mg/kg per inj., irrespective of the dose order 
within a session. Greater variability across 
dose-presentation order was noticeable at 0.001 
and 0.003 mg/kg per inj.; however, few 
consistent trends in rates as a function of dose 
order appeared across monkeys. The only 
possible exception to this was when the dose 
order was 0.601,0,0.01 and 0.003 mg/kg per inj. 
In this order, the dose of 0.003 mg/kg per inj 
was consistently self-administered at lower 
rates than when it was available earlier in the 
order. Although, in the case of monkey 1618, 
rates of responding maintained by 0.001 mg/kg 
per inj were considerably higher when this 
dose was third in the dose order, as compared 







0 0.001 0.003 0.01 
Fig. 2. The effect of order of dose presentation on rate of responding maintained by cocaine in each of three monkeys. The 
numbers at the top of each column indicate the order (first, second, third or fourth) of that particular dose in a daily sequence of 
dose presentation. Four unique sequences were used, selected so that each dose was in a different position across the four 
sequences. The columns are averages of four observations of rates of responding maintained by the indicated doses in the indi- 
cated sequence orders. Vertical lines are standard errors of the mean. 
order effect was not observed in the other two 
monkeys. Closer examination of data from 
monkey 1618 indicated that this effect was 
most likely a sampling error; similar order 
effects were not observed in another sample of 
sessions. 
When several doses/infusion of nomifensine 
were substituted for cocaine within single ses- 
sions, nomifensine was found to maintain 
responding as well (Fig. 31. In two of the three 
monkeys evaluated with nomifensine, the drug 
appeared nearly identical to cocaine in both 
potency and efficacy. It was slightly more 
potent than cocaine in the third monkey (4890. 
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Ke tamine-baseline 
The ability of ketamine, phencyclidine and 
MK-301 to maintain responding using this pro- 
cedure was compared in three monkeys 
maintained on a baseline of ketamine self- 
administration. As shown in Fig. 4, phen- 
cyclidine was as effective as ketamine as a 
reinforcer: both drugs produced increases in 
response rates as dose/injection was increased, 
and showed similar maximum rates of respond- 
ing. Phencyclidine was approximately ten 
times more potent than ketamine as a 
reinforcer. MK-301 also appeared to be more 






























0 0.001 0.01 0.1 
MG/KG/INJ 
Rates of responding maintained by cocaine and by nomifensine in each of three monkeys. Nomifensine was presented 
twice to monkey 489C, once using a dose range of O.OOl- 0.01 mg/kg per inj. and once using a dose range of 0.003- 0.03 mg/kg 
per inj. Nomifensine was presented four times to monkey R639, once at a dose range of 0.0001-0.001 mg/kg per inj. once at a 
dose range of 0.0003-0.003 mg/kg per inj. and twice at a dose range of 0.001-0.01 mg/kg per inj. Nomifensine was presented 
four times to monkey 1618, each time at the dose range of 0.001-0.01 mg/kg per inj. Comparative data on rates of responding 
maintained by cocaine were obtained from the session just prior to that in which nomifensine was substituted, with the addi- 
tion, in the case monkeys R639 and 489C, of two and three sessions, respectively, in which a higher dose range of cocaine (0.003 










0.0001 0.001 0.01 0.1 
2.50 - 
El 08 
A 2.50 - 
48X 
2.00 - 2.00 - 
1.50- + 1.50- 
l.OO- 1.00. 
0.50- A 0.50 - 
0.00 J , v- * 4 0.007 
0 0.0001 0.001 0.01 0.1 c, 0.001 0.01 0.1 
MG/KG/INJ 
Fig. 4. Rates of responding maintained by ketamine, phencyclidine and MK-801 in each of three monkeys who were experi- 
enced with ketamine self-administration. Phencyclidine was presented to monkey El08 once at a dose range of 0.0003-0.003 
mg/kg per inj. and twice at a dose range of 0.001 - 0.01 mg/kg per inj.; to monkey 485C twice at a dose range of 0.0003 - 0.003 
m&kg per inj. and three times at a dose range of 0.001-0.01 mg/kg per inj.; to monkey 1942 once at a dose range of 0.0003- 
0.003 mg/kg per inj. and four times at a dose range of 0.001-0.01 mg/kg per inj. Each of the three monkeys was tested with 
MK-801 on several occasions (12 times for monkey 1942, nine times for monkey E108, and six times for monkey 485C) at dose 
range from 0.00003 to 0.03 mg/kg per inj. Comparative data on rates of responding maintained by ketamine were obtained from 
the sessions just prior to those in which phencyclidine or MK-801 was substituted. 
rates of responding that were as high as those 
maintained by phencyclidine or ketamine (Fig. 
41. A fairly wide range of doses of MK-801 was 
evaluated in these monkeys; in one subject 
(1942) MK-801 produced a fairly flat dose-effect- 
curve rather than the sharply increasing dose- 
effect curve that developed with the other 
tested drugs. The dose-effect curve was stee- 
per in the other two monkeys, but did not reach 
the same maximum as did ketamine or 
phencyclidine. 
Discussion 
In the current procedure, as in the previous 
procedure, each drug tested maintained self- 
administration behavior, and the dose of drug 
tested was the strongest determinant of rates 
of responding. Each drug except MK-801 was 
more potent in maintaining behavior in the cur- 
rent procedure than it was in the previous 
procedure. This is to be expected since, with 
shorter time out periods between infusions (45 
s vs. 10 min), lower doses of drug should main- 
tain rates of responding. In studies by Downs 
and Woods [4], in which various doses of cocaine 
were available on an FR 30 schedule with no 
time out period, the maximum rate of 
responding occurred at a dose of 0.003 mg/kg 
per inj. In contrast, with the same fixed ratio 
parameters but with a lo-min time out period 
between injections, the maximum rate of 
responding occurs at a dose of 0.32 mg/kg per 
inj. cocaine [5]. 
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The data suggest that the influence of time 
out duration on the rate of drug-maintained 
responding is relatively greater if the drug is 
short acting. Cocaine, a very short-acting com- 
pound, maintained maximum rates of 
responding at 0.32 mg/kg per inj. in the original 
procedure [5] and at 0.01 mg/kg per inj. in the 
current procedure, a difference of 1.5 logarithm 
units. Nomifensine and ketamine, both short- 
acting drugs, showed a difference of 1 
logarithm unit between the two procedures (0.1 
mg/kg per inj. [5] vs. 0.01 mg/kg per inj. for nom- 
ifensine, 1.0 mg/kg per inj. (unpublished 
observations) vs. 0.1 mg/kg per inj. for 
ketamine). Phencyclidine, with a longer 
duration of action, showed a difference of l/2 
logarithm unit (0.03 mg/kg per inj. [6] vs. 0.01 
mg/kg per inj.1 in the two procedures. There 
was little difference in the potency of MK-801 in 
the two procedures; the maximum rate-main- 
taining effect in both was 0.003 mg/kg per inj. 
[6]. In our experience, MK-801 has a slower 
onset of action and a longer duration of action 
than does phencyclidine. It might be expected 
that, if drug accumulation is important in 
determining rates of drug-reinforced respond- 
ing, responding maintained by drugs with 
longer durations of action, drugs that 
accumulate nearly equally with either a 45 s or 
a lo-min time out, would be less influenced by 
time out duration than shorter acting drugs. 
Although there were inconsistent differ- 
ences among potencies of various drugs in the 
current procedure as compared with the 
previous procedure, there was little difference 
in the relative magnitude of the drugs’ effects. 
Cocaine and nomifensine maintained nearly 
equal maximum rates of responding in the prior 
procedure, and nearly equal maximum rates of 
responding in the current procedure. Absolute 
rates of responding maintained by cocaine and 
nomifensine were somewhat higher in the prior 
procedure, but individual differences in rates of 
responding are often large in both procedures, 
and the significance of these differences is 
probably slight. 
In the prior procedure, rates of responding 
maintained by the baseline dose of ketamine 
(0.56 mg/kg per inj.1 were slightly higher than 
the maximum rates maintained by phencycli- 
dine in two of the three monkeys and were 
nearly identical for the third monkey [6]. In the 
current procedure, ketamine and phencyclidine 
maintained equal rates in one monkey, 
phencyclidine maintained higher rates in one 
monkey and ketamine maintained slightly 
higher rates in one monkey. Thus, there was 
little overall difference in the two procedures. 
Patterns of self-administration of MK-801 were 
similar in the two procedures in that the slope 
of the curve relating dose of drug to rate of 
responding was relatively shallow. Also, MK- 
801 did not maintain as high a rate of 
responding in either procedures as did phency- 
clidine or ketamine. 
It thus appears that a procedure in which 
several doses of a drug are available for self- 
administration in a single session can provide 
data very comparable to data obtained in a par- 
adigm in which only a single dose of drug is 
evaluated in a single session. The most impor- 
tant advantage of this procedure is that it 
allows dose-effect curves, relating dose of drug 
to rate of responding, to be obtained quickly. In 
comparison to the procedure described by 
Woods [l], in which 6 days were the minimum 
necessary to determine the effects of three 
doses of drug on rate of responding, a similar 
dose-effect curve can be obtained in 130 min 
using the procedure described here. Other 
procedures in which each dose of a drug is 
substituted for the baseline drug for several 
days [e.g., 71 may require even longer periods to 
obtain a dose-effect curve. Yet, although the 
potency relations among and within drugs may 
vary from procedure to procedure, the differ- 
ent procedures agree quite well when asking 
the general question of whether a particular 
drug is a reinforcer or not. 
A rapid procedure for evaluation of drug 
self-administration behavior can be helpful in a 
number of situations. For example, studies of 
the effects of a large number of potential drug 
intervention strategies on drug self-adminis- 
tration are more feasible in this procedure. The 
rapidity of obtaining dose-rate curves also 
allows evaluations that would be difficult or 
impossible to obtain in some of the other 
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procedures. The effects of tolerance and 
dependence on drug self-administration are dif- 
ficult to measure using most protocols, because 
the amount of tolerance and dependence can 
vary during the intervals between evaluation 
of the reinforcing effects of various drug doses. 
In the current procedure, shifts in dose-effect 
curves as a function of chronic drug admini- 
stration can be evaluated in a short period of 
time, before additional physiological changes 
occur. We hope that applications of this proce- 
dure will provide much additional information 
on characteristics of drugs of abuse. 
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